AI Visibility Scorecard
TECARTUS® (brexucabtagene autoleucel) Patient & Caregiver Site
tecartus.com · Healthcare
Borderline visible. AI bots can crawl TECARTUS® (brexucabtagene autoleucel) Patient & Caregiver Site, but the structured-data signals are thin - you are at real risk of being skipped when buyers ask ChatGPT, Claude, or Perplexity for a recommendation.
AI engines read this profile 9 times
Meta AI · Claude · Apple Intelligence · ShapBot
#31,301 of 924,300 in Healthcare for AI visibility
2
AI Naming Predictability
iRarely named · 2/100
More likely to be named than 95% of Healthcare companies
5
AEO Visibility
iBorderline · 4.6/10
5
Muse Index Score
iAI agent readiness
Basic · 5/100
0
AI Adoption
iNone detected · 0/100
About TECARTUS® (brexucabtagene autoleucel) Patient & Caregiver Site
from our crawl and measurement
TECARTUS® (brexucabtagene autoleucel) Patient & Caregiver Site describes itself simply: "Learn about TECARTUS® (brexucabtagene autoleucel) a CAR T-cell therapy for R/R mantle cell lymphoma and acute lymphoblastic leukemia in adults. See Important Safety Information & Warnings." When AI engines look at it, they find little to work with. It scores 4.6 out of 10.
Our crawl found a sitemap. It is missing structured data describing the business, an llms.txt file and a heading structure that lays out what it offers.
AI crawlers have visited once in our tracking, including ClaudeBot (Anthropic).
The 6 signals AI reads
Strong · Good · Fair · Weak
Structured Data
Weak
Organization / LocalBusiness JSON-LD that AI can read.
Content Structure
Good
Clear headings and answer-style content.
Entity Clarity
Fair
How clearly your brand identity reads to AI.
E-E-A-T Signals
Experience, Expertise, Authority, Trust
Fair
Experience, Expertise, Authority, Trust markers.
Technical AEO
Good
robots.txt, llms.txt, and AI-bot crawl access.
AI Discoverability
Fair
Sitemaps and entity links AI can follow.
Off-page authority
How the web signals your brand to AI
Backlinks
Strong
Inbound links from other sites.
Domain Authority
Weak
Little domain authority yet.
Reference Presence
Weak
Not in AI knowledge graphs yet.
News & Press
Weak
No press coverage found yet.
Community
Weak
No community discussion yet.
Social Mentions
Weak
No social discussion found yet.
What this score means
Your AEO score measures whether AI search engines - ChatGPT, Claude, Perplexity, Gemini - can actually read your site and cite it in answers. Roughly two-thirds of sites are invisible to them. At 4.6/10, TECARTUS® (brexucabtagene autoleucel) Patient & Caregiver Site is crawlable but under-signaled - fixable, and the signals above are where to start.
Is this your brand?
The exact fixes for TECARTUS® (brexucabtagene autoleucel) Patient & Caregiver Site
Which AI engines already crawl you
Free AI bot monitoring: see every AI crawler that visits you
Already have an account? Sign in
How to Get Your Brand Cited by ChatGPT, Gemini, and Claude: The Complete AEO Guide
The search landscape has fundamentally shifted. While Google still dominates, millions of users now ask questions to ChatGPT, Gemini, and Claude instead of typing into a search bar.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for TECARTUS® (brexucabtagene autoleucel) Patient & Caregiver Site.
Source & Attribution
Scored by Engagemii on August 10, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/tecartus
Cite this score: Engagemii (2026). "AEO Score for TECARTUS® (brexucabtagene autoleucel) Patient & Caregiver Site." Retrieved from https://engagemii.com/aeo/brands/tecartus
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - The Answer Engine Optimization (AEO) Platform